Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
88.73
+2.14 (2.47%)
At close: Jul 19, 2024, 4:00 PM
10.18
-78.55 (-88.52%)
After-hours: Jul 20, 2024, 1:23 PM EDT
Haemonetics Employees
Haemonetics had 3,657 employees as of March 30, 2024. The number of employees increased by 623 or 20.53% compared to the previous year.
Employees
3,657
Change (1Y)
623
Growth (1Y)
20.53%
Revenue / Employee
$357,959
Profits / Employee
$32,146
Market Cap
4.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 30, 2024 | 3,657 | 623 | 20.53% |
Apr 1, 2023 | 3,034 | 213 | 7.55% |
Apr 2, 2022 | 2,821 | 113 | 4.17% |
Apr 3, 2021 | 2,708 | -296 | -9.85% |
Mar 28, 2020 | 3,004 | -212 | -6.59% |
Mar 30, 2019 | 3,216 | 80 | 2.55% |
Mar 31, 2018 | 3,136 | 29 | 0.93% |
Apr 1, 2017 | 3,107 | -118 | -3.66% |
Apr 2, 2016 | 3,225 | -158 | -4.67% |
Mar 28, 2015 | 3,383 | -399 | -10.55% |
Mar 29, 2014 | 3,782 | 219 | 6.15% |
Mar 30, 2013 | 3,563 | 1,226 | 52.46% |
Mar 31, 2012 | 2,337 | 136 | 6.18% |
Apr 2, 2011 | 2,201 | -126 | -5.41% |
Apr 3, 2010 | 2,327 | 311 | 15.43% |
Mar 28, 2009 | 2,016 | 141 | 7.52% |
Mar 29, 2008 | 1,875 | 49 | 2.68% |
Mar 31, 2007 | 1,826 | 165 | 9.93% |
Apr 1, 2006 | 1,661 | 161 | 10.73% |
Apr 2, 2005 | 1,500 | 0 | - |
Apr 3, 2004 | 1,500 | 3 | 0.20% |
Mar 29, 2003 | 1,497 | -1 | -0.07% |
Mar 30, 2002 | 1,498 | 141 | 10.39% |
Mar 31, 2001 | 1,357 | 29 | 2.18% |
Apr 1, 2000 | 1,328 | -1 | -0.08% |
Apr 3, 1999 | 1,329 | -67 | -4.80% |
Mar 28, 1998 | 1,396 | -130 | -8.52% |
Mar 29, 1997 | 1,526 | 275 | 21.98% |
Mar 30, 1996 | 1,251 | -31 | -2.42% |
Mar 30, 1995 | 1,282 | 173 | 15.60% |
Mar 30, 1994 | 1,109 | 107 | 10.68% |
Mar 30, 1993 | 1,002 | 37 | 3.83% |
Mar 30, 1992 | 965 | 42 | 4.55% |
Mar 30, 1991 | 923 | 113 | 13.95% |
Mar 30, 1990 | 810 | 68 | 9.16% |
Mar 30, 1989 | 742 | -38 | -4.87% |
Mar 30, 1988 | 780 | 155 | 24.80% |
Mar 30, 1987 | 625 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Integer Holdings | 10,500 |
RadNet | 7,872 |
Alkermes | 2,100 |
Inspire Medical Systems | 1,011 |
Apellis Pharmaceuticals | 702 |
TransMedics Group | 584 |
BridgeBio Pharma | 550 |
CRISPR Therapeutics AG | 407 |
HAE News
- 13 days ago - Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 - PRNewsWire
- 4 weeks ago - Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device - PRNewsWire
- 2 months ago - Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes - PRNewsWire
- 2 months ago - Haemonetics Announces Proposed Convertible Senior Notes Offering - PRNewsWire
- 2 months ago - Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website - PRNewsWire
- 3 months ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 - PRNewsWire
- 3 months ago - Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge - PRNewsWire
- 3 months ago - Haemonetics Corporation Completes Acquisition of Attune Medical - PRNewsWire